Related Experiment Video
Updated: Aug 4, 2025

Author Spotlight: Developing a Translational Model for Atrial Fibrillation Research Across Species
Published on: November 21, 2023
Bigeminal superior vena cava activity with potent arrhythmogenicity
Hiroka Nakashima1, Shunsuke Kawai1, Arihide Okahara1
1Department of Cardiovascular Medicine Japanese Red Cross Fukuoka Hospital Fukuoka Japan.
The superior vena cava can trigger atrial fibrillation (AF). Bigeminal activity in thoracic veins, originating from the superior vena cava, is a key factor in AF episodes during catheter ablation.
Area of Science:
- Cardiology
- Electrophysiology
- Cardiac Arrhythmias
Background:
- Atrial fibrillation (AF) is a common arrhythmia.
- The superior vena cava (SVC) is recognized as a significant source of AF triggers.
- Understanding specific triggers within the SVC is crucial for effective AF management.
Purpose of the Study:
- To investigate the role of superior vena cava bigeminy as a trigger for atrial fibrillation.
- To highlight the clinical significance of thoracic vein bigeminal activity in the context of AF catheter ablation.
Main Methods:
- Analysis of electrophysiological data during AF catheter ablation procedures.
- Identification and characterization of bigeminal activity originating from the superior vena cava and adjacent thoracic veins.
Main Results:
- Superior vena cava bigeminy was identified as a specific trigger mechanism for AF.
- These bigeminal activities in thoracic veins were found to be relevant during AF ablation procedures.
Conclusions:
- Superior vena cava bigeminy represents an important trigger for atrial fibrillation.
- Clinicians performing AF catheter ablation should carefully assess and address bigeminal activities in the thoracic veins, particularly those related to the SVC.
More Related Videos
06:57Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
Published on: January 31, 2019
09:36Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Mechanism of Cardiac Arrhythmias
Dysrhythmias III: Characteristics of Dysrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...